# Autoimmune and Inflammatory Disorders

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the association between neutrophilic dermatoses, such as Pyoderma Gangrenosum and Sweet's Syndrome, and inflammatory bowel diseases. It covers various aspects including clinical features, treatment strategies, pathophysiology, and potential links with autoinflammatory skin disorders. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t12328 |
| Works | 117 |

## Topic papers all

Showing 15 of 117.

- [Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies](https://scholariq.org/papers/worldwide-incidence-and-prevalence-of-inflammatory-bowel-disease-in-the-21st/)
- [Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease](https://scholariq.org/papers/ustekinumab-as-induction-and-maintenance-therapy-for-crohn-s-disease/)
- [Ulcerative colitis](https://scholariq.org/papers/ulcerative-colitis-2/)
- [Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial](https://scholariq.org/papers/secukinumab-a-human-anti-il-17a-monoclonal-antibody-for-moderate-to-severe-crohn/)
- [Pediatric modification of the Montreal classification for inflammatory bowel disease](https://scholariq.org/papers/pediatric-modification-of-the-montreal-classification-for-inflammatory-bowel/)
- [The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria](https://scholariq.org/papers/the-international-criteria-for-behcet-s-disease-icbd-a-collaborative-study-of-27/)
- [A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies](https://scholariq.org/papers/a-randomized-trial-of-maintenance-therapy-for-vasculitis-associated-with/)
- [Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.](https://scholariq.org/papers/anti-neutrophil-cytoplasmic-autoantibodies-induce-neutrophils-to-degranulate-and/)
- [Ulcerative Colitis](https://scholariq.org/papers/ulcerative-colitis-3/)
- [Crohn’s disease](https://scholariq.org/papers/crohn-s-disease/)
- [The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations](https://scholariq.org/papers/the-second-european-evidence-based-consensus-on-the-diagnosis-and-management-of/)
- [Incidence and Phenotype of Inflammatory Bowel Disease Based on Results From the Asia-Pacific Crohn's and Colitis Epidemiology Study](https://scholariq.org/papers/incidence-and-phenotype-of-inflammatory-bowel-disease-based-on-results-from-the/)
- [AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis](https://scholariq.org/papers/aga-clinical-practice-guidelines-on-the-management-of-moderate-to-severe/)
- [The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update](https://scholariq.org/papers/the-medical-management-of-paediatric-crohn-s-disease-an-ecco-espghan-guideline/)
- [A comprehensive review and update on ulcerative colitis,](https://scholariq.org/papers/a-comprehensive-review-and-update-on-ulcerative-colitis/)

## Topic primary papers

- [ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease](https://scholariq.org/papers/ecco-guidelines-on-extraintestinal-manifestations-in-inflammatory-bowel-disease/)
- [Diagnosis and treatment of pyoderma gangrenosum](https://scholariq.org/papers/diagnosis-and-treatment-of-pyoderma-gangrenosum/)
- [Autoinflammatory Skin Disorders in Inflammatory Bowel Diseases, Pyoderma Gangrenosum and Sweet’s Syndrome: a Comprehensive Review and Disease Classification Criteria](https://scholariq.org/papers/autoinflammatory-skin-disorders-in-inflammatory-bowel-diseases-pyoderma/)
- [Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet’s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants](https://scholariq.org/papers/evidence-based-diagnosis-and-clinical-practice-guidelines-for-intestinal-behcet/)
- [Metastatic Cutaneous Crohn’s Disease in Children: Case Report and Review of the Literature](https://scholariq.org/papers/metastatic-cutaneous-crohn-s-disease-in-children-case-report-and-review-of-the/)
- [<p>Disseminated <em>Talaromyces marneffei</em> And <em>Mycobacterium avium</em> Infection Accompanied Sweet’s Syndrome In A Patient With Anti-Interferon-γ Autoantibodies: A Case Report</p>](https://scholariq.org/papers/and-lt-p-and-gt-disseminated-and-lt-em-and-gt-talaromyces-marneffei-and-lt-em/)
- [Lipschütz ulcer:](https://scholariq.org/papers/lipschutz-ulcer/)
- [Pulmonary Symptoms as the First Manifestation of Crohn’s Disease](https://scholariq.org/papers/pulmonary-symptoms-as-the-first-manifestation-of-crohn-s-disease/)
- [Nonhealing Leg Ulcer as the Presentation of Sarcoidosis: A Case Report](https://scholariq.org/papers/nonhealing-leg-ulcer-as-the-presentation-of-sarcoidosis-a-case-report/)
- [Beriliosis: una granulomatosis para no olvidar la importancia de la historia laboral](https://scholariq.org/papers/beriliosis-una-granulomatosis-para-no-olvidar-la-importancia-de-la-historia/)
- [Incidental Hepatic Granulomata as the Initial Presentation of Crohn's Disease in a Pediatric Patient](https://scholariq.org/papers/incidental-hepatic-granulomata-as-the-initial-presentation-of-crohn-s-disease-in/)
- [DOENÇA DE CROHN COMO DIAGNÓSTICO DIFERENCIAL NA ANEMIA CRÔNICA: RELATO DE CASO](https://scholariq.org/papers/doenca-de-crohn-como-diagnostico-diferencial-na-anemia-cronica-relato-de-caso/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.